Type 1 but not type 2 calreticulin mutations activate the IRE1a/XBP1 pathway of the unfolded protein response to drive myeloproliferative neoplasms.
暂无分享，去创建一个
R. Schneider | S. Oakes | S. Koschmieder | E. Rumi | D. Pietra | S. Gurbuxani | M. Evers | Chenyu Liu | I. Casetti | Michele Ciboddo | Shannon E Elf | Milena Kalmer | Julian Baumeister | Althea Bock-Hughes | Diane Silva | S. Catricalà | J. Lutze | Harrison S Greenbaum | Katarzyna Kuryłowicz | Quinn Smith | Kathrin Olschok | Jonathan L Dowgielewicz | Juan Ibarra | Yassmin A Elbanna | Nicole S Arellano | Luke Maxwell | D. Rodríguez | Benjamin Nicholson